Skip to Contents
Joint Patent Application Filed for lncRNA-Targeting Drugs
Aug 3, 2026
サブ-ナビゲーション
NEWS
ABOUT US
CEO MESSAGE
BOARD MEMBER
AI
DRUG DELIVERY
TECHNOLOGY
SCIENTIFIC ADVISOR
PUBLICATION
GROWTH STRATEGY
INVESTOR RELATIONS
Management Information
Message from our CEO
Company Profile
Corporate Governance
Financial Highlights
Business Results
Financial Position
IR Library
【削除禁止】決算短信・説明会資料(自動連携)
Financial Results
Financial Briefing Materials
Stock Information
Basic Stock Information
Stock Quotes
現在位置:
IR News
RECRUIT
CONTACT
PRIVACY POLICY
Sitepolicy
Joint Patent Application Filed for lncRNA-Targeting Drugs
Aug 3, 2026